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Abstract: Poxviruses replicate in the cytoplasm, where they acquire multiple lipoprotein 
membranes. Although a proposal that the initial membrane arises de novo has not been 
substantiated, there is no accepted explanation for its formation from cellular membranes. 
A subsequent membrane-wrapping step involving modified trans-Golgi or endosomal 
cisternae results in a particle with three membranes. These wrapped virions traverse the 
cytoplasm on microtubules; the outermost membrane is lost during exocytosis, the middle 
one is lost just prior to cell entry, and the remaining membrane fuses with the cell to allow 
the virus core to enter the cytoplasm and initiate a new infection. 
Keywords:  phospholipids; transmembrane proteins; virus entry; endocytosis; virus 
assembly; exocytosis 
 
1. Introduction 
The  Poxviridae is a family of large, complex, enveloped DNA viruses that infect a variety of 
vertebrate and invertebrate hosts. Poxviruses are of significance both medically and scientifically due 
to their wide distribution, pathogenicity, and unique cytoplasmic replicative life cycle  [1]. Several 
prominent members, including variola virus (causative agent of smallpox), molluscum contagiosum 
virus (cause of a common skin infection of young children and immunosuppressed adults) and 
monkeypox virus (agent of a smallpox-like disease in parts of Africa), are of considerable concern for 
public health and biodefense. The prototypic and most studied poxvirus – vaccinia virus (VACV) – 
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serves as an effective smallpox vaccine, a platform for recombinant vaccines against other pathogens 
and an efficient gene expression vector for basic research [2-4]. 
Along its approximate 195-kbp double-stranded DNA genome, VACV encodes ~200 proteins, 
ranging in function from viral RNA and DNA synthesis and virion assembly to modulation of host 
immune defenses [1]. The most abundant and simplest infectious form of the poxvirus particle – the 
mature virion (MV; alternate name: intracellular mature virion [IMV]) – consists of the viral DNA 
genome encased in a proteinaceous core and an outer lipoprotein membrane with ~60 and ~25 
associated viral proteins, respectively [5]. The presence of an inner membrane forming one layer of the 
core wall has been suggested by cryo-electron tomography [6] but not yet verified by other methods.  
Following attachment to cell surfaces and fusion with the plasma or endosomal membrane, poxvirus 
replication is initiated by entry of the viral core into the cytoplasm where all subsequent steps of the 
life cycle take place  [7]. Poxvirus cores harbor the viral DNA-dependent RNA polymerase and 
transcription factors necessary for expression of early genes, which constitute nearly half of the viral 
genome and encode proteins needed for DNA replication and intermediate gene transcription as well 
as a large number of immunomodulators  [1]. Poxviruses exhibit a temporally-regulated gene 
expression program, i.e., expression of early genes encoding DNA replication and intermediate 
transcription factors triggers the expression of intermediate genes encoding late gene specific 
transcription factors [8]. Late gene products primarily consist of structural proteins needed for progeny 
virion assembly as well as those enzymes destined for incorporation into progeny virions and used for 
early gene expression during the next round of infection.  
Assembly of the MV involves more than 80 viral gene products [5]. In addition, during transit 
through the cytoplasm, a subset of progeny MVs acquires two additional membrane bilayers, one of 
which is lost during exocytosis of the particle, to yield the less abundant enveloped virion (EV; 
alternate names: cell-associated enveloped virion [CEV] and extracellular enveloped virion [EEV]). 
Thus, an EV is essentially an MV with an additional membrane in which at least six unique proteins 
are associated  [9]. Of note, EVs are antigenically distinct from MVs  [10] and are important for 
efficient virus dissemination in the infected host and protection against immune defenses  [9]. In 
contrast, MVs are released upon cell lysis and may be important for animal-to-animal transmission.  
This review highlights the role of lipoprotein membranes in poxvirus entry into cells and during the 
assembly, morphogenesis and egress of progeny virions. 
2. Review 
2.1. Roles of membranes and lipids in cell entry 
2.1.1. Entry of MVs 
MVs have been subjected to the great majority of VACV entry studies primarily because they can 
be highly purified, are stable and are the simplest infectious particle. In addition, the MV is the form 
used for vaccination. The initial attachment of MVs to cells occurs, in part, through interactions 
between viral membrane proteins (D8, A27, H3, and A26) and cell surface glycosaminoglycans 
(specifically, chondroitin sulfate and heparan sulfate) or laminin; however, individually these proteins 
are not essential [11-14]. Viral-cell membrane fusion and entry of the virus core into the cytoplasm can Viruses 2010, 2                                       
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occur at neutral pH at the cell surface, as evidenced by numerous electron micrographs and suggested 
by biochemical membrane fusion assays [15-19]. Electron micrographs have also visualized the uptake 
of MVs into vesicles [20]. These observations were reconciled in a recent study showing that both 
fusion at the plasma membrane and endosomal vesicles can occur even in the same cell  [21] 
(Figure  1). Further studies showed that the predominant mechanism of entry of the WR strain of 
VACV is by a low pH-dependent mechanism [21] following macropinocytosis  [22,23]. The situation 
remains complicated, however, as there are VACV strain differences regarding the relative 
contributions of low and neutral pH entry mechanisms [24]. 
In terms of the number of proteins required, VACV membrane fusion is far more complex than any 
other studied viral system. At least twelve MV membrane proteins (A16, A21, A28, G3, G9, H2, J5, 
L5, O3, I2, L1 and F9) – nine or ten of which function in a multi-protein complex termed the 
entry/fusion complex (EFC) – are individually required [25-35]. Two EFC proteins (A16 and G9) and 
the EFC-associated L1 protein are myristoylated, but the significance of these lipid moieties in virus 
entry has not been determined.  
Figure 1. Cell entry pathways of vaccinia virus mature virions (MV) and enveloped virions 
(EV) following attachment at the cell plasma membrane. Depending on the VACV strain 
and target cell, MV cores can enter the cytosol either through direct fusion of the MV 
membrane with the plasma membrane (A) or, following endocytosis/macropinocytosis, 
through fusion of the MV membrane with vesicles (B). EV particles have been observed to 
shed their additional membrane bilayer prior to direct fusion of the underlying MV 
membrane with the cell plasma membrane (C); entry of EV through an endosomal route 
might also occur. White arrowheads denote sites of membrane fusion between the MV 
particle membrane and cellular membranes. 
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2.1.2. Lipids of the MV membrane 
Lipids, mostly phospholipids and cholesterol, constitute approximately 5% of the MV mass [36]. 
The MV contains several phospholipids with an abundance of phosphatidylcholine and lesser amounts 
of phosphatidylethanolamine, phosphatidylinositol, and phosphatidylserine (PS) [37-39]. An additional 
phospholipid, semilysobisphosphatidic acid (also known as acylbis(monoacylglycero)phosphate or 
acylphosphatidylglycerol) has been identified in MVs [39,40]. Quantitation of the lipids in the MV by 
Cluett and Machamer [39] is shown in Table 1. The lipid composition likely reflects the cellular origin 
of the MV membrane. 
Early studies by Ichihashi and Oie demonstrated the importance of virion-incorporated PS for 
VACV MV infectivity  [41,42]. Extraction of virion-associated lipids with Nonidet P-40 detergent 
rendered MVs non-infectious, but incubation with either crude uninfected cell membrane preparations 
or PS-containing liposomes partially restored infectivity [41,42]. More recently, these results were 
extended and an apoptotic mimicry model for poxvirus entry, in which virion-associated PS 
specifically served to flag virions as apoptotic debris for cell uptake by macropinocytosis, was 
proposed  [23]. However, PS is not unique in its ability to trigger this uptake mechanism as the 
reconstitution of detergent-extracted MVs with several other anionic phospholipid species could also 
facilitate virus entry in the absence of PS [43]. Nonetheless, these studies indicated the importance of 
the MV membrane lipid composition, specifically the presence of anionic phospholipid species, in cell 
entry of VACV MVs. 
Table 1. Quantitation of phospholipids in vaccinia virus MV and WV 
µg per 10
10 virions 
Phospholipid MV  WV  WV-MV 
N-acyl phosphatidylethanolamine  0.38  0.31  0 
Semilysobisphosphatidic acid  1.2  3.2  2 
Phosphatidylethanolamine 1.7  4.5 2.8 
Phosphatidylserine 0.26  1.3  1 
Phosphatidylinositol 1  2.2  1.2 
Phosphatidylcholine 2.8  7.8  5 
Sphingomyelin 0.6  2.1  1.5 
Data from Cluett and Machamer [39]. 
 Viruses 2010, 2                                       
 
 
976
2.1.3. Entry of EVs and the EV-specific membrane 
The EV contains an additional outer membrane compared to the MV. Relative to MVs, EVs were 
reported to be enriched in sphingomyelin and PS with lower amounts of phosphatidylinositol [38]. In a 
later section, we will discuss the origin and phospholipid composition of the wrapped virion, which 
contains an additional membrane relative to the EV. MVs and EVs bind differently to cells [44] but 
little is known regarding the mechanism or proteins required for binding of the latter particles. Entry of 
EVs necessitates rupture of the outer membrane to expose the EFC embedded in the MV 
membrane  [7] (Figure 1). Electron micrographs reveal a clear dissociation of the EV membrane 
“wrapper” from individual particles at the cell surface; importantly, no continuity of the EV wrapper 
with the plasma membrane was observed confirming that it is not fusogenic  [45]. This “ligand-
dependent non-fusogenic dissolution” of the outer EV membrane requires the EV membrane 
glycoproteins A34 and B5 and interactions with cell surface polyanionic molecules, e.g., 
glycosoaminoglycans, following virus attachment [45,46]. The subsequent entry steps are reported to 
be low pH-dependent [47]. 
2.1.4. Lipids and protein components of the target cell membrane 
Cell surface glycosaminoglycans and laminin are important for the initial attachment of MVs to the 
cell surface  [11,13,14,48]. The binding of MVs to cells induces the formation of actin-enriched 
membrane protrusions that engulf the virus particles for entry by macropinocytosis; this cellular 
response involves actin rearrangements and Rac1 GTPase as well as several serine/threonine, tyrosine, 
and phosphatidylinositol kinases including Pak1, PKC, and PI(3)K [23,49]. In contrast to MVs, entry 
of EVs does not seem to be signaling dependent [49]. Specific cell receptors, for either the MV or EV 
forms of VACV, have not been identified. Although PS-specific receptors for MV have been 
suggested [23], this is unlikely since a subsequent study indicated that PS is not uniquely involved in 
entry [43]. Depletion of cellular cholesterol levels does not affect cell binding of MVs but significantly 
inhibits entry of viral cores [50] indicating the importance of the composition and organization of the 
plasma membrane and suggesting a role for lipid rafts. Indeed, the block in MV penetration of 
cholesterol-depleted cells was found to occur at the initial stages of virus-cell membrane fusion 
(Laliberte and Moss, unpublished). Although the precise role of cellular cholesterol in VACV 
membrane fusion is not known, it may be indirectly required for triggering specific cell signaling 
pathways by cell surface-bound MVs. Additionally, reduced levels of cholesterol in the target cell 
membrane may affect cell surface distribution of an unidentified cell receptor(s) or other factor(s) 
required for virus entry.  
2.2. Role of membranes and lipids during morphogenesis and egress of progeny virions 
2.2.1. Membranes associated with virus factories and immature virions (IVs) 
After virus-cell membrane fusion, viral cores are actively transported on microtubules away from 
the cell periphery and deeper into the cytoplasm [51], where early gene transcription occurs. DNA 
from a single core may serve as a template for genome replication forming a viral factory [52-54]. Viruses 2010, 2                                       
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Remarkably, at an early stage, each individual factory is entirely surrounded by ER membranes [55]. It 
has been suggested that the latter membranes are associated with replicating DNA. Following viral 
DNA replication and subsequent intermediate gene expression, the accumulation of late gene products 
– including viral structural proteins and enzymes/early gene transcription factors destined for virus 
packaging – allows poxvirus assembly and morphogenesis. The highly complex process of generating 
progeny virions is orchestrated by more than 80 viral gene products [5].  
Viral membranes play a pivotal role in virion assembly. The initial structure observed by electron 
microscopy is the viral crescent membrane, which expands to form the spherical immature virion (IV) 
(Figure 2). The number of lipid bilayers comprising the viral crescent and IV membranes has been the 
subject of controversy. Electron microscopic images from several different laboratories were 
consistently interpreted as showing a single bilayer with an external spicule border  [56-61]. 
Nevertheless, others interpreted their images as demonstrating two closely apposed 
bilayers [38,62,63]. The controversy appears to have been settled as no evidence for two bilayers was 
obtained by freeze-fracture studies [64] and the initial proponents of the double bilayer now also favor 
a single bilayer [65]. The spicule border on the crescent and IV membrane has been shown to be a 
honeycomb lattice scaffold composed of trimers of the viral D13 protein [64,66]; it is possible that the 
separation of this protein scaffold from the underlying membrane provided images suggesting a double 
membrane bilayer. 
Neither the crescent nor the IV membrane has been extensively purified and characterized so their 
lipid compositions remain unknown. The composition is usually inferred to be that of the MV 
membrane. A number of viral protein components of the crescent and IV membrane have been 
determined by immunoelectron microscopy and will be discussed below. 
Figure 2. Enumeration of lipid membrane bilayers (white arrowhead) possessed by 
vaccinia virus assembly intermediates. Nucleoids (nu) are electron-dense, DNA-containing 
substructures of immature virions. Lateral bodies (L) are internal virion structures of 
heterogenous material surrounding the dumbbell-shaped viral core (C). The location of 
each morphogenic form is indicated below the respective schematic.  
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2.2.2. Assembly of the IV membrane 
The unusual appearance of the crescent and IV membranes in cytoplasmic virus factories and their 
separation from cellular organelles led to the idea of their de novo synthesis  [56]. However, the 
unprecedented nature of spontaneous membrane formation encouraged efforts to find a cellular 
organelle from which the viral membrane might be derived. Electron microscopic images have 
depicted close association of membranes of the ER-Golgi apparatus intermediate compartment 
(ERGIC) with IVs  [38,63,67,68] while others have shown a close association with ER 
membranes [69]. Nevertheless, direct continuity between cellular organelles and viral membranes has 
not been demonstrated unambiguously. Although viral membrane proteins have been detected by 
immunogold labeling in ERGIC and ER, the reverse has not been shown, i.e., cellular proteins in 
crescent or IV membranes. ERGIC resident proteins have also not been detected in purified MV 
particles, the membrane of which is presumably derived from the IV [70]. The lipid profile of purified 
MV particles was interpreted as being consistent with the MV membrane being of intermediate 
compartment or cis-Golgi network origin [39]. However, inhibiting transport of proteins from the ER 
to the Golgi compartment does not prevent the formation of IVs and MVs [71], implying that IV 
membranes are not derived from the ERGIC or Golgi compartment. Additional studies have shown 
that viral proteins can transit directly through the ER to the IV and accumulate in the MV 
membrane [69].  
In addition to the viral D13 scaffold protein, several membrane (A14 and A17)  [72] and non-
membrane (A11, F10, G5, and H5) [73-77] viral proteins are required for crescent formation, whereas 
other proteins such as A9 [78] associate with the crescent membrane but are required at a later stage of 
morphogenesis. The exact roles of A14 and A17 proteins in crescent formation are uncertain but in the 
absence of either membrane protein crescent formation is reduced or aberrant and small vesicles 
accumulate [79-82].  
Elongation and closure of viral crescents around electron dense viroplasm, containing core proteins 
or their precursors, give rise to the spherical IVs, which are approximately 350 nm in diameter [5] 
(Figure 2). Association of viroplasm with crescents is dependent on the expression of a complex of 
seven viral core proteins (A15, A30, D2, D3, F10, G7, and J1) [83]. Following packaging of the viral 
genome, the IV particle undergoes a gross alteration to become a barrel-shaped particle distinctive of 
poxvirus MVs. This transition is accompanied by disassembly of the viral D13 scaffold [84] and the 
processing of core protein precursors  [85,86]. Virion assembly has recently been reviewed in 
detail [5]. Although crucial for progeny virion infectivity, the EFC as well as the EFC-associated 
proteins L1 and F9 are dispensable for the MV morphogenesis. 
2.2.3. Membranes of the enveloped particle 
As described earlier, after completion of MV morphogenesis, some particles are actively 
transported along microtubules away from the viral factory to sites where wrapping  [87,88] with 
modified cisternae of endosomal  [89] or trans-Golgi  [90,91] origin occurs. These wrapped virions 
(WV; alternate name: intracellular enveloped virion [IEV]) possess an MV membrane and two 
additional membrane bilayers (Figure 2). The phospholipids of the WV have been analyzed and the 
composition of the wrapping membrane inferred by subtracting the values for the MV from the Viruses 2010, 2                                       
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WV  [39] (Table 1). The phospholipid components of the WV, with the exception of N-acyl 
phosphatidylethanolamine, are present in 2 to 3 times the molar amount of the MV, consistent with 
additional lipid bilayers in the WV (Table 1). At least seven proteins are associated with the wrapping 
membrane: A33, A34, A36, A56, B5, F12, F13. Of these, A36 and F12 are located exclusively on the 
outermost WV membrane. Although the details by which MVs acquire these membranes are unclear, 
the process requires the expression of several viral proteins, including the MV membrane-associated 
A27 protein [88,92] and the WV membrane-associated B5 [93,94] and F13 proteins [95]; other WV 
associated viral proteins appear necessary for efficient MV particle wrapping (reviewed in [9]). Of 
note, the peripheral F13 membrane protein is palmitylated on a pair of cysteine residues and addition 
of these 16-carbon fatty acid tails is necessary for membrane association, proper localization, and 
function of F13 [90,96,97]. The importance of the F13 protein is consistent with the potency both in 
vitro and in vivo of the anti-poxvirus therapeutic ST-246, which inhibits F13 protein activity in the 
infected cell [98]. 
Wrapped virions are transported to the cell periphery in a microtubule-dependent manner relying on 
an interaction between the motor protein kinesin-1 and the viral A36 protein [99] and the viral F12 
protein  [100]. Once near the plasma membrane, the WV particle traverses the cortical membrane 
cytoskeleton by enhancing microtubule dynamics near the cell surface and inducing reorganization of 
the actin cytoskeleton resulting from the inhibition of RhoA signaling by the viral F11 
protein [101,102]. Following dissociation from microtubules, the outermost membrane bilayer fuses 
with the plasma membrane resulting in the exocytosis of a doubly-wrapped EV at the cell surface. It is 
likely that cellular mechanisms are used for this exocytosis step since no viral mutants that have a 
phenotype in which virions collect under the cell surface have been isolated. Most of the exocytosed 
particles remain attached to the exterior of the cell and have been referred to as cell-associated EVs 
(CEV) to distinguish them from the released EVs (alternate name: extracellular enveloped virions 
[EEV]) [103]. The cell-associated EVs are largely responsible for cell-to-cell spread at the tips of actin 
tails. 
3. Conclusions 
Lipoprotein membranes have crucial roles at key stages of the poxvirus life cycle, namely entry, 
assembly, intracellular transport, exocytosis and spread. The MV membrane is comprised of 
phospholipids and numerous proteins that together enable attachment and fusion with either the plasma 
membrane or endocytic vesicles following macropinocytosis. After entry of the core into the 
cytoplasm, ER membranes surround the early viral factories within which DNA replication occurs. 
The very first recognizable viral structures in the factories are crescent membranes of yet unknown 
origin that engulf viroplasm, containing core proteins, to form IVs. The external lattice scaffold 
responsible for the spherical shape of the IV detaches from the membrane allowing further steps in 
morphogenesis resulting in the barrel or brick-shaped MV. The latter acquires two additional 
lipoprotein membranes, derived from trans-Golgi or endosomal cisternae modified by the insertion of 
viral proteins, that allow high speed transit of the triple-membrane layered virions on microtubules. 
Upon reaching the periphery of the cell, the outermost viral membrane fuses with the plasma 
membrane resulting in exocytosis of the double-membrane EV. Upon contacting an uninfected cell, Viruses 2010, 2                                       
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usually at the end of a long actin-containing projection, the outer membrane is disrupted allowing 
fusion of the MV membrane with the cell and penetration of the viral core into the cytoplasm for 
continuation of the replicative cycle.  
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